Chugai Pharma USA Revenue

Pharmaceutical Manufacturing • Japan • 201-500 Employees

Chugai Pharma USA revenue & valuation

Annual revenue	$15,000,000
Revenue per employee	$65,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$48,000,000
Total funding	No funding

Key Contacts at Chugai Pharma USA

Angela Edmonds

Director, Head Of Human Resources & General Affairs

Snigdha Santra

Director, Business Insights And Strategy

Jane Royalty

Medical Director

Stanislava Prather

Director, Early Clinical Development

Tsuyoshi Kobayashi

Study Manement Group Lead, Director Of Early Clinical Development Dept.

Jessica Lin

Director Of Clinical Operation

Audrey Zaweski

Associate Director

Hiroaki Nagashima

Director, Pharmaceutical Technical Leader Cmc Leader

Jumpei Kobayashi

Excexutive Scientific Director

一昕丁

Finance Director

Company overview

Headquarters	Japan
Phone number	+19085161350
Websites	chugai-pharm.co.jp chugai-pharm.co.jp
NAICS	3254
Employees	201-500

Chugai Pharma USA Email Formats

Chugai Pharma USA uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@chugai-pharm.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@chugai-pharm.com	66.7%
{first name}.{last name}	john.doe@chugaipharma.de	33.3%

About Chugai Pharma USA

Chugai’s strength in R&D and antibody technologies continues on in global efforts for products and services for the benefit of patients. Chugai Pharma USA, Inc. (CPUSA), located in Berkeley Heights, NJ, is a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd. (Chugai). CPUSA supports the planning and execution of global and U.S. clinical programs for Chugai-originated, innovative new drug candidates. Chugai is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs in Chugai’s strategic fields of oncology, bone and joint diseases, and renal diseases as well as other therapeutic areas with serious unmet needs. Chugai develops its products independently from Roche until early Proof-of-Concept (PoC) for worldwide market, including U.S. For late stage clinical development and marketing outside of Japan, South Korea, and Taiwan, Chugai seeks for partnership with Roche, which has the first refusal rights to develop/sell Chugai products, or other third parties. For a list of Chugai’s current research projects please visit: http://www.chugai-pharm.co.jp/english/ir/reports_downloads/pipeline.html

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry

Manager

Director

Employees by Department

Chugai Pharma USA has 52 employees across 11 departments.

Departments

Number of employees

Funding Data

Chugai Pharma USA has never raised funding before.

Frequently asked questions

Chugai Pharma USA is located in JP.

You can reach Chugai Pharma USA at +19085161350.

Chugai Pharma USA generates an estimated annual revenue of $15,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Chugai Pharma USA has an estimated valuation of $48,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Chugai Pharma USA has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.